Two U.S. Adult Stem Cell Companies Form Collaboration in Asia
The biotech companies Neostem and Regenerative Sciences have signed a licensing agreement for the commercialization of adult stem cell technology throughout Asia.
May 11, 2009
The biotech companies Neostem and Regenerative Sciences have signed a licensing agreement for the commercialization of adult stem cell technology throughout Asia.
At its Analyst Day Meeting today, the biotech company Genzyme announced new updates to clinical data and business developments.
Cytori Therapeutics and GE Healthcare announce a marketing collaboration for adult stem cell technology.
In yet another merger of Big Pharma and academia, two of the world’s leading research entities join forces for combined stem cell R&D.
British scientists turn fetal stem cells into auditory receptors in an animal model.
The Texas Heart Institute in Houston is currently enrolling patients with various cardiovascular conditions for clinical adult stem cell trials.
Toll Free:
1-800-980-STEM (7836)
Outside or Inside US Call:
1-954-358-3382
Toll Free Fax (US Only):
1-866-755-3951
From Outside US Fax:
1-775-887-1194
Copyright 2025, Stem Cell Insitute Panama. All rights reserved.